| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acdc1987bae1eb38052703db93219085 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 |
| filingDate |
2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3a28d2966d4281fde0af4e3bb745337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa6210ebef84237c8cc04210296fa535 |
| publicationDate |
2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018154401-A1 |
| titleOfInvention |
Non-invasive brain injury diagnostic device |
| abstract |
Provided herein is a device for conducting a non-invasive diagnostic test in a subject suspected of suffering brain injury. The device for diagnosing a brain injury in a subject includes a probe of a porous matrix, an indicator formulation disposed on the porous matrix and comprises at least one lectin and/or antibody capable of selectively binding to a glycan-based biomarker indicative of brain injury in a sample, and a visually detectable label; and a handle in communication with the probe, wherein at least one of the lectin and/or antibody and/or the visually detectable label is immobilized in and/or on a detection zone in the porous matrix, and the visually detectable label develops a color intensity level and becomes visible upon a binding event of the glycan-based biomarker to the lectin and/or antibody. Also provided is a method for using the device described below and methods for producing the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021205059-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021099677-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202023100246-U1 |
| priorityDate |
2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |